HomeOVID • NASDAQ
add
Ovid Therapeutics Inc
Previous close
$2.30
Day range
$2.02 - $2.31
Year range
$0.24 - $2.72
Market cap
318.67M USD
Avg Volume
3.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 718.00K | 844.74% |
Operating expense | 13.01M | 44.60% |
Net income | 9.66M | 204.43% |
Net profit margin | 1.35K | 111.05% |
Earnings per share | 0.06 | 146.15% |
EBITDA | -12.28M | -40.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 69.64M | 31.20% |
Total assets | 150.93M | 63.76% |
Total liabilities | 20.27M | -15.32% |
Total equity | 130.66M | — |
Shares outstanding | 131.87M | — |
Price to book | 2.30 | — |
Return on assets | -28.62% | — |
Return on capital | -30.35% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 9.66M | 204.43% |
Cash from operations | -10.41M | -4.00% |
Cash from investing | -72.06M | -438.45% |
Cash from financing | 75.18M | — |
Net change in cash | -7.46M | -166.09% |
Free cash flow | -6.52M | -29.44% |
About
Founded
2014
Website
Employees
23
